← Back
Data updated: Mar 10, 2026
RENATA
CardiovascularNeurology
RENATA is a generic drug manufacturer focused on Cardiovascular, Neurology.
1995
Since
5
Drugs
-
Trials
125
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
METOLAZONE 2026-01-07
Manufacturing (CMC)
RISPERIDONE 2025-11-04
Labeling
METOPROLOL TARTRATE 2025-09-15
Labeling
RISPERIDONE 2025-09-11
Labeling
METOPROLOL TARTRATE 2025-09-03
Labeling
METOPROLOL TARTRATE 2025-09-03
Labeling
METOPROLOL TARTRATE 2025-09-03
Labeling
RISPERIDONE 2025-09-02
RISPERIDONE 2025-09-02
RISPERIDONE 2025-08-13
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 67%
2 drugs
Neurology 33%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (1)
Company Info
- First Approval
- 1995-04-27
- Latest
- 2025-09-03
- Applications
- 5